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Abstract
Scrapie in sheep and goats has been known for more than 250 years and belongs nowadays to the so-called prion
diseases that also include e.g. bovine spongiform encephalopathy in cattle (BSE) and Creutzfeldt-Jakob disease in
humans. According to the prion hypothesis, the pathological isoform (PrP
Sc) of the cellular prion protein (PrP
c)
comprises the essential, if not exclusive, component of the transmissible agent. Currently, two types of scrapie
disease are known - classical and atypical/Nor98 scrapie. In the present study we examine 24 cases of classical and
25 cases of atypical/Nor98 scrapie with the sensitive PET blot method and validate the results with conventional
immunohistochemistry. The sequential detection of PrP
Sc aggregates in the CNS of classical scrapie sheep implies
that after neuroinvasion a spread from spinal cord and obex to the cerebellum, diencephalon and frontal cortex
via the rostral brainstem takes place. We categorize the spread of PrP
Sc into four stages: the CNS entry stage, the
brainstem stage, the cruciate sulcus stage and finally the basal ganglia stage. Such a sequential development of
PrP
Sc was not detectable upon analysis of the present atypical/Nor98 scrapie cases. PrP
Sc distribution in one case of
atypical/Nor98 scrapie in a presumably early disease phase suggests that the spread of PrP
Sc aggregates starts in
the di- or telencephalon. In addition to the spontaneous generation of PrP
Sc, an uptake of the infectious agent
into the brain, that bypasses the brainstem and starts its accumulation in the thalamus, needs to be taken into
consideration for atypical/Nor98 scrapie.
Introduction
Scrapie in sheep and goats, which has been reported for
more than 250 years [1], belongs to the transmissible
spongiform encephalopathies (TSEs) - also known as
prion diseases. This group of fatal diseases includes
bovine spongiform encephalopathy (BSE) in cattle,
chronic wasting disease (CWD) in deer and Creutzfeldt-
Jakob disease (CJD) in humans. TSEs are characterized
by the accumulation of protein aggregates, which are
relatively stable against proteolysis. According to the
prion hypothesis, a misfolded protein is the relevant
part of the infectious agent [2]. It is widely accepted
that this “proteinaceous infectious particle” is the patho-
logical isoform of the physiological prion protein (PrP
c)
which is encoded by a cellular gene [3]. Recently, it has
been shown that infectivity can be generated from a
synthetic misfolded form of the prion protein [4].
Depending on the kind of prion disease, the pathological
prion protein (PrP
Sc) is detectable solely in the central
nervous system (CNS) or may also be found in other tis-
sues, especially in those of the lymphoreticular system
(LRS) [5].
In the worldwide population of small ruminants, BSE
and scrapie are considered to be the relevant TSEs affect-
ing sheep and goats. Scrapie, however, is not a homoge-
nous disease form, as demonstrated by the existence of
several strains upon transmission to rodents [6] and the
peculiar molecular properties of the sheep-passaged scra-
pie isolate CH1641 [7,8]. The discovery of a novel type of
scrapie in Norway in 1998 (Nor98) that was clearly dis-
tinguishable from all previously reported forms of scrapie
[9], and that was soon after detected in several other
countries, added to the diversity of this TSE [10]. In our
present work we concentrate on scrapie field cases that
include cases of “classical” scrapie as well as “atypical"/
Nor98 scrapie. Obvious differences exist between the two
scrapie forms with regard to the epidemiology of the
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The latter include Western blot profiles and the stability
against denaturation and proteases [11-13]. The two
forms of sheep scrapie also differ with regard to the gen-
otypes affected. Amino acids at codon 136 (A/V), 154
(H/R) and 171 (H/Q/R) are considered to markedly influ-
ence susceptibility to classical scrapie; the most suscepti-
ble alleles are V136R154Q171 (VRQ) and A136R154Q171
(ARQ), while the A136R154R171 allele (ARR) seems to con-
fer a certain resistance against the disease [14,15]. Atypi-
cal/Nor98 scrapie affects a number of genotypes,
including the ARR allele, and animals with the AHQ
allele or a Phenylalanin (F) instead of Leucin (L) at codon
141 in the ARQ allele are proportionally overrepresented
[16-18].
The results of a number of case reports and studies
have shown that the deposition form and distribution of
PrP
Sc aggregates in atypical/Nor89 scrapie sheep are
clearly distinct from classical scrapie; immunohisto-
chemical methods and recently the sensitive PET blot
method have been used for the detection of PrP
Sc in the
ovine brain [9,19-23]. Formerly, the PET blot had only
been used for the sensitive detection of PrP
Sc in extra-
cerebral organs of classical scrapie sheep [24-27]. Sur-
prisingly, the anatomical distribution of PrP
Sc in the
ovine brain found in the literature is more thoroughly
documented for atypical/Nor98 scrapie than for classical
scrapie. Although the pathogenesis of classical scrapie is
well-studied [28,29], detailed descriptions on how the
infectious agent spreads once it has reached the brain
seem to be lacking for both scrapie types. For classical
scrapie, numerous reports exist on the different forms
of PrP
Sc that can be found in the brain tissue and the
presence of PrP
Sc aggregates in peripheral neural and
non-neural tissues - at least in sheep carrying suscepti-
ble PrP genotypes. Also, the entry of the infectious
agent into the CNS has been described thoroughly for
field classical scrapie infections and has been shown to
agree with the oral infection of sheep with BSE and
scrapie as well as the oral infection of rodent models
infected with scrapie [29-32]. The infectious agent
apparently enters the CNS via the intermediolateral col-
umn of the thoracic spinal cord (Th8 -T h 10 in natural
scrapie infection) and the dorsal motor nucleus of the
vagus nerve (DMNV) in the brainstem. Unfortunately,
reports on the spread of ovine PrP
Sc from the brainstem
into the brain are usually not very detailed. In atypical/
Nor98 scrapie, most of the PrP
Sc load in affected sheep
is found in the cerebellum and cerebrum. It still needs
to be determined whether this novel disease is a spora-
dic prion disease or not. If sheep could acquire the dis-
ease from their environment, where would the
infectious agent enter the CNS? The pattern of PrP
Sc
deposition is apparently reproduced when atypical/
Nor98 scrapie is transmitted from one sheep to another
via intracerebral inoculation [33].
In this study the PrP
Sc deposition pattern in the CNS
of 24 classical and 25 atypical/Nor98 field scrapie sheep
was determined using the sensitive and specific PET
blot method. Different amounts of PrP
Sc in the CNS of
classical scrapie have been assigned to different stages of
PrP
Sc spread into the brain, depending on the affected
neuroanatomical structures.
Materials and methods
Material
The brains and, if available, the spinal cords as well as
l y m p h a t i ct i s s u e( t o n s i l sa n d /or retropharyngeal lymph
nodes) were collected from 49 scrapie field cases and 6
further sheep from scrapie-free flocks as controls. Scra-
pie positivity was diagnosed either ante mortem by ton-
sil biopsy or post mortem using the respective methods
stipulated by the EU VO999/2001 at that time (samples
were collected during a time span of 12 years). The
scrapie-positive group included 19 German and 5 Nor-
wegian sheep diagnosed with classical scrapie and 24
Norwegian atypical/Nor98 scrapie cases, plus one
German atypical/Nor98 case. The control group was
made up of six German sheep derived from scrapie-free
flocks. The PrP genotypes were determined either by
PCR and melting curve analysis [34] or by automated
sequencing as described previously [9]. Further informa-
tion on the individual animals including age, breed, gen-
otype, presence of clinical signs and availability of LRS
and spinal cord is listed in Table 1.
Depending on the circumstances under which the
samples were collected, the post mortem times of tissues
varied between 2 h and 4 days. Usually one half of the
brain/tonsil/lymph node was fixed in 4% buffered for-
maldehyde, cut into slices and embedded in paraffin
within five to seven days, while the other half was frozen
and stored at -80 °C.
Histopathology
One to three μm-thick CNS/lymphatic tissue sections
were cut, collected on silane-coated glass slides and
stained with haematoxylin and eosin (H&E). Brain sec-
tions were also stained with Luxol Fast Blue then coun-
terstained by periodic acid Schiff` reagent (LFB/PAS) for
the orientation and discrimination of neuronal nuclei
and neural tracts.
PET blot
The PET blot procedure followed the protocol as
described previously [23,35] using the monoclonal anti-
body (mAb) P4 (R-Biopharm, Darmstadt, Germany),
which had proved to give the best results regarding sen-
sitivity and specificity for the detection of PrP
Sc in
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Page 2 of 14Table 1 Genotype, age, breed, the presence of clinical signs and the availability of lymphatic tissue and spinal cord of
the individual sheep
Genotype Breed Age in
months
Lymphatic tissue
available
Spinal cord
available
Clinical signs
present
Classical
scrapie cases
ARQ/ARQ G.M./B.M. crossbreed ~42 yes yes no
ARQ/ARQ G.M./B.M. crossbreed ~24 yes yes no
ARQ/ARQ G.M./B.M. crossbreed >48 yes yes no
ARQ/ARQ Black headed Mutton ~72 yes yes no
ARQ/ARQ German Merino ~60 yes yes yes
ARQ/ARQ German Merino >48 yes yes yes
ARQ/ARQ G.M./B.M. crossbreed >48 yes yes yes
ARQ/ARQ G.M./B.M. crossbreed unknown yes no unknown
ARQ/ARQ G.M./B.M. crossbreed ~48 yes no unknown
ARQ/ARQ Black headed Mutton unknown yes no unknown
ARQ/ARQ B.M./Mountain sheep crossbreed 27 yes yes yes
ARQ/ARQ G.M./B.M./Mountain sheep
crossbreed
25 yes yes yes
ARQ/ARQ B.M./Mountain sheep crossbreed unknown yes yes yes
ARQ/ARQ B.M./Mountain sheep crossbreed 29 yes yes no
ARQ/ARQ B.M./Mountain sheep crossbreed 38 yes yes yes
VRQ/ARQ Texel unknown yes no unknown
VRQ/ARQ Norwegian pelt sheep ~24 yes no unknown
VRQ/ARQ Steigar sheep ~42 no no unknown
VRQ/ARQ Texel unknown yes no unknown
VRQ/ARQ Steigar sheep unknown no no unknown
VRQ/ARQ Texel/Mountain sheep crossbreed 32 yes yes yes
VRQ/ARH Texel 30 yes yes no
VRQ/ARH Steigar sheep unknown yes no unknown
VRQ/ARH Texel unknown yes no unknown
Atypical/
Nor98
scrapie cases
AFRQ/ARQ Spæl sheep ~78 no no uncertain
AFRQ/AHQ Suffolk/Rygja/Steigar crossbreed ~72 no yes yes
ARQ/AHQ German Merino unknown yes no unknown
AHQ/AHQ Steigar sheep ~48 yes yes yes
AHQ/AHQ Spæl sheep ~72 yes no yes
AHQ/AHQ Norwegian white sheep ~84 yes no yes
AHQ/AHQ Spæl sheep ~42 yes yes uncertain
AHQ/AHQ Spæl sheep ~48 yes no yes
AHQ/AHQ Spæl sheep ~72 no no yes
AHQ/ARH Norwegian white sheep ~120 yes no yes
AHQ/AFRQ Dala sheep ~84 no yes yes
AHQ/AFRQ Steigar sheep ~60 no no yes
AFRQ/
AFRQ
Norwegian white sheep ~60 yes no uncertain
AFRQ/
AFRQ
Dala sheep ~36 yes yes yes
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immunolabeling of PrP
Sc was performed after a 1-3 μm
tissue section had been placed on a nitrocellulose mem-
brane (0.45 μm, Bio-Rad, Hercules, CA, USA) which
was then deparaffinized and rehydrated. This was fol-
lowed by treatment with proteinase K (250 μg/mL;
Sigma-Aldrich, MO, USA) overnight at 56 °C and the
decontamination of the membranes in 4 M guanidine
thiocyanate (GdnSCN) for 30 min. Membranes were
blocked with 0.2% casein in PBS containing 1% Tween
before the primary antibody (mAbP4) was applied
1:5000 in TBST. An alkaline phosphatase-coupled goat-
anti-mouse antibody (Dako, Glostrup, Denmark) and
the formazan-reaction with NBT/BCIP were used to
visualize the result. Thorough rinsing of the membranes
with TBST was required between the different steps.
Immunohistochemistry
Tissue sections on silane-coated glass slides were stained
with one of the primary mAbs P4, L42 (R-Biopharm,
Darmstadt, Germany), F89/160.1.5 (Veterinary Medical
Research and Developement, Pullman, WA, USA), and
12F10 (kindly provided by W Bodemer and D Motzkus,
German Primate Center), which were used 1:500 in
combination with an alkaline phosphatase-coupled goat
anti-mouse antibody (Dako) and neufuchsine as chro-
mogene as described previously [23]. Alternatively, a
commercially available kit from Dako (Envision AEC,
Glostrup, Denmark) was applied by using mAb F89/
160.1.5 at a dilution of 1:2000 in combination with the
mAb 2G11 (1:200, kindly provided by J Grosclaude
(INRA, Jouy-en-Josas, France)).
Examination and evaluation of immunolabelled sections
From each sheep all available sections of the CNS and
the LRS were examined with the PET blot, and the
intensity of the PrP
Sc staining as well as the forms and
distribution of the PrP
Sc deposition were evaluated. The
presence of PrP
Sc deposits and the deposition forms in
CNS and LRS sections were verified by immunohisto-
chemistry. This was usually done using either mAb P4
(German cases) or mAb F89/160.1.5 in combination
with mAb 2G11 (Norwegian cases), but if considered
necessary immunohistochemistry was repeated with
further antibodies as stated above. The intensity of
PrP
Sc deposits in the PET blots was evaluated on a scale
of 0.5 to 4 (0 = no PrP
Sc deposits visible; 0.5 = very little
indefinable deposits; 1 = very little distinct PrP
Sc depos-
its; 1.5 = little distinct PrP
Sc deposits; 2 = moderate
PrP
Sc deposits, all deposition forms well distinguishable;
2.5 = moderate to pronounced PrP
Sc deposits, all
deposition forms well distinguishable; 3 = pronounced
PrP
Sc deposits, deposition forms partly interfere with
each other; 3.5 = pronounced PrP
Sc deposits, deposition
Table 1 Genotype, age, breed, the presence of clinical signs and the availability of lymphatic tissue and spinal cord of
the individual sheep (Continued)
AFRQ/
AFRQ
Norwegian white sheep ~78 yes no yes
AFRQ/
AFRQ
Rygja/Dala crossbreed ~84 yes no uncertain
AFRQ/
AFRQ
Dala sheep ~108 yes no no
AHQ/ARR Spæl sheep ~72 no no yes
AHQ/ARR Norwegian white sheep ~96 yes no no
AHQ/ARR Dala sheep ~72 yes no uncertain
AHQ/ARR Dala sheep ~84 no yes no
ARR/AFRQ Norwegian white sheep ~96 no no unknown
ARR/AFRQ Norwegian white sheep ~66 yes no no
ARR/ARR Steigar ~84 no yes no
unknown Rygja/Dala crossbreed unknown no no no
Control
cases
ARQ/ARQ Skudde unknown yes no no
ARR/ARH Leine 30 yes no no
ARR/ARR German Merino ~132 yes no no
ARR/ARR Leine ~60 yes no no
ARR/ARR Leine ~96 yes no no
ARR/ARR Leine >48 yes no no
B.M. = blackheaded mutton, G.M. = German Merino.
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Sc depos-
its, deposition forms interfere with each other). The
value system of the scale itself was established and
agreed on by two independent persons that routinely
evaluate PET blots.
Western blot analysis
Ten percent tissue homogenates (wt/vol) were either
prepared in PBS containing 0.5% desoxycholic acid
sodium salt (DOC) using glass grinding tubes and pes-
tles or 20% homogenates were obtained by the standard
sampling procedure of the TeSeE Western Blot Kit (Bio-
Rad, Hercules, CA, USA).
Twenty percent homogenates were processed using
the TeSeE sheep/goat Western Blot Kit according to the
manufacturer’s instructions. The antibody P4 was added
at a dilution of 1:1000 to the primary antibody of the
kit. Ten percent homogenates were subjected to a differ-
ent protocol using homemade 15% acrylamid gels, a
0.45 μm nitrocellulose (NC) membrane (Bio-Rad) for
semi-dry blotting and mAbP4 (1:2000). The membrane
was treated with 4 M GdnSCN and blocked with 0.2%
casein in PBS including 1% Tween for 30 min respec-
tively before the primary antibody was applied overnight
at 4 °C. An HRP-conjugated goat anti-mouse antibody
(Dako, Carpintera, CA, USA) and Super Signal Femto
West Maximum Sensitivity Substrate (Perbio, Erembo-
degem, Belgium) were used to visualize the result on
x-ray film. The molecular size of PrP
Sc was compared
only within one system.
Results
Western blot
In all sheep that had been classified as atypical/Nor98
scrapie cases, the characteristic small fragment of 11-
12 kDa [9] was present in CNS tissue samples after pro-
teinase K digestion. Hereof the typical triplet pattern of
18-30 kDa in all classical scrapie sheep was clearly dis-
tinguishable. We usually used CNS tissue for Western
blotting to determine the molecular profile. Only in one
sheep with classical scrapie PrP
Sc were amounts in the
brainstem so minimal that lymphatic tissue was needed
to perform a valid Western blot. To ensure that Wes-
tern blot PrP
Sc patterns of different tissues were com-
parable in one sheep, lymphatic tissues of further sheep
with classical scrapie (from this study) were examined as
well.
PET blot and immunohistochemistry
Disease-associated prion protein could be identified in
the CNS of all scrapie sheep with the PET blot and
there was no PrP
Sc detectable in the tissues of the nega-
tive control group. As previously described, immunohis-
tochemical methods were able to confirm the presence
of PrP
Sc deposits in all sheep except for one atypical/
Nor98 case, despite using of a panel of antibodies [23].
Immunolabeling with the PET blot method allowed
the identification of a number of deposition forms of
PrP
Sc in the CNS and all were confirmed by immuno-
histochemical methods.
As described before [23] PrP
Sc was detectable in the
LRS tissue of all classical scrapie sheep where it was
present, but in none of the atypical/Nor98 scrapie ani-
mals with available LRS tissue could PrP
Sc be found (for
availability of lymphatic tissue see Table 1). Figure 1a/b
shows PET blot and immunohistochemical staining of
the PrP
Sc aggregates in the follicle of a tonsil derived
from a classical scrapie case.
Deposition forms
Intra- and perineuronal PrP
Sc aggregates were found
with the PET blot solely in classical scrapie (Figure 1f),
as were subpial, subenpendymal, and perivascular depos-
its. Extra neuronal PrP
Sc aggregates in the brains of
sheep affected by classical scrapie often had a ramified
appearance and were found in grey and white matter
structures (Figure 1d and 1f). They were addressed as
glia-associated PrP
Sc aggregates and found to be rela-
tively conspicuous in the cerebellar molecular layer
where they took a stellate form [36] (Figure 1d).
In contrast, PrP
Sc aggregates found in the white
matter of atypical/Nor98 scrapie sheep were always
well-defined granules that varied a bit in size and were
occasionally arranged like pearls on a string. The latter
deposition form could also be observed in classical
cases, but here also linear PrP
Sc was sometimes present.
PrP
Sc deposits in the grey matter of atypical/Nor98 scra-
pie cases generally showed a fine granular pattern, also
termed “synaptic/reticular” in human TSEs rather than
“fine granular” [12,37] (see Figure 1c). In some atypical/
Nor98 scrapie cases, larger plaque-like aggregates could
be seen in the substantia nigra, basal ganglia, thalamic
nuclei and white matter. However, a differentiation
between real plaques (amyloid) and plaque-like deposits
is not possible with immunohistochemical detection
methods or with the PET blot method as demonstrated
before [38].
A discrimination between globular and punctuate
deposits in the white matter of atypical/Nor98 cases
[11,21] was irreproducible with the PET blot, which is
why the term “granular” for the PrP
Sc deposits that were
present in the white matter was chosen. Punctuate PrP
Sc
deposits, comprising smaller aggregates than granular
PrP
Sc deposits but more defined than the reticular PrP
Sc
aggregates, were detected in the grey matter of classical
scrapie sheep.
Small deviations in the composition of the complex
deposition pattern could not be related to genotypes in
the sheep examined.
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Sc deposition patterns in classical and atypical/Nor98 scrapie: The same lymph follicle in the tonsil of a sheep
with classical scrapie is shown stained either with the PET blot method (a) or conventional immunohistochemistry (b) (both mAb P4, bars =
250 μm). In the cervical spinal cord segment of a sheep with atypical/Nor98 scrapie (c) stained with the PET blot method (mAb P4, bar = 800
μm) synaptic PrP
Sc aggregates are present in the substantia gelatinosa (vertical arrow) and granular PrP
Sc in the corticospinal tract (horizontal
arrows). In the cerebellar cortex of a classical scrapie sheep stained with the PET blot (d) complex PrP
Sc deposits are visible. Glia-associated PrP
Sc
deposits take a stellate form in the molecular layer (mAb P4, bar = 150 μm; M = molecular layer, P = layer of Purkinje cells, G = granular cell
layer). In the majority of the atypical/Nor98 scrapie sheep the cerebellar cortices show a more intense staining of the molecular layer than the
granular layer (e) (PET blot, mAb P4; bar 600 μm). Intraneuronal, perineuronal and glia-associated PrP
Sc aggregates (f) in the reticular formation of
a classical scrapie sheep (PET blot, mAb P4; bar = 50 μm). Tissue sections derived from sheep with the genotypes VRQ/ARH (a,b), AHQ/AHQ (c,e)
and ARQ/ARQ (d,f).
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Sc in the CNS
Sequential appearance of PrP
Sc distribution in the
CNS of classical scrapie sheep To determine the
sequential appearance of PrP
Sc in the CNS, all field
cases of classical scrapie were subjected to a thorough
examination regarding the anatomical structures affected
by PrP
Sc deposition. In the following, all cases were
arranged according to the amount of PrP
Sc they had
accumulated in total, and the occurrence of PrP
Sc in a
panel of 127 neuroanatomical loci was compared
between the cases. From this evaluation arose a classifi-
cation of the classical scrapie cases into four stages of
PrP
Sc spread in the CNS (see Figures 2, 3, 4 and 5). Cri-
teria for these turned out to be certain neuroanatomical
Figure 2 Classification of the PrPSc spread during disease development in classical scrapie.The examined classical scrapie cases classified
into four stages of PrP spread according to certain affected neuroanatomical sites (PET blots, mAb P4). In the CNS entry stage (a - d) only
discrete PrP
Sc deposits are visible in the obex region, while in the brainstem stage (e - h) PrP
Sc aggregates are clearly visible in the brainstem
and start to appear in more rostral structures. Once PrP
Sc deposits can be found in the deep cortical layers of the frontal cortex (i), the cruciate
sulcus stage (i - l) is reached. In the basal ganglia stage, intense deposits in basal ganglia and thalamic nuclei can be found (m - p). Brain
sections shown for the first, third and fourth stage derived from sheep with the genotype ARQ/ARQ while the sheep whose brain sections are
depicted in the brainstem stage carried the genotype ARH/VRQ (bar = 5 mm).
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Page 7 of 14structures whose involvement marked a stage, meaning
that the respective structure accumulated PrP
Sc aggregates
(with a minimal score of 1) in all animals belonging to this
stage and the following stage/stages. They are described in
detail below and visualized in Figures 3 and 4.
Figure 3 Progression of classical scrapie in the brain shown
for certain affected neuroanatomical sites. The colour code
agrees with the one in Figure 5.
Figure 4 Accumulation of PrP
Sc in different brain regions
during disease progression: The four stages of the examined
classical scrapie cases are depicted in four overlying graphs that
illustrate how PrP
Sc aggregates (PET blot method, mAb P4) are
increasingly accumulated in the brains from caudal (left) to rostral
(right). Evaluation of PrP
Sc intensity was performed on a scale from
0.5 - 4 (see material and methods) and shown for the following
brain areas: 1 dorsal motor nucleus of the vagus nerve (DMNV), 2
inferior olive, 3 dorsal tegmental nucleus, 4 cerebellar molecular
layer, 5 cerebellar granular layer, 6 cerebral peduncle, 7 central grey
(mesencephalon), 8 caudate nucleus, 9 ventral pallidum, 10 rostral
commissure, 11 cruciate sulcus, 12 frontal white matter.
Figure 5 Form and appearance of PrP
Sc deposits in classical
and atypical/Nor98 scrapie sheep presented for representative
CNS regions. As a sequential development of PrP
Sc distribution
could not be observed upon analysis of the present atypical/Nor98
scrapie cases, no coding colours were used for the results of this
scrapie type in contrast to classical scrapie sheep. PrP
Sc deposits are
detectable in the respective location in classical scrapie sheep
belonging to the stages of spread indicated in the bottom of the
figure using the same colour code as in Figure 3.
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PrP
Sc deposits in the brain that were restricted to the
dorsal motor nucleus of the vagus nerve (DMNV), the
solitary tract nucleus and the spinal trigeminal tract in
the brainstem. Further PrP
Sc aggregates could be
detected in the substantia intermedialis lateralis and
centralis of the thoracic spinal cord. This first stage,
where PrP
Sc is detectable only in these CNS areas, can
be considered the “CNS entry stage” in accordance with
studies of other authors who have monitored the ascen-
sion of PrP
Sc from the intestines to the CNS [29,30].
Brainstem stage: In the second stage, all segments of
the spinal cord and all nuclei of the obex region accu-
mulate PrP
Sc which also disseminates to the more ros-
tral parts of the medulla; this may therefore be called
“brainstem stage”. In the caudal medulla the cellulae
marginales and substantia gelatinosa of the spinal tri-
geminal tract nucleus show a very intense staining. The
mesencephalon and thalamus display discrete PrP
Sc
deposits which are generally found to be subpial and/or
perivascular while the mamillary body, habenular nuclei
and the hypothalamic nuclei accumulate substantial
amounts of PrP
Sc. The cerebellar nuclei accumulate
PrP
Sc if the rostral medulla is largely involved and focal
deposits of PrP
Sc are visible in the cerebellar cortex.
Cruciate sulcus stage: During the next stage, the
mesencephalon, amygdaloid nuclei, septal nuclei, optic
tract, cerebral peduncle, hippocampus formation, frontal
cortex and subcortical white matter are increasingly
affected. Regarding the frontal cortex, it is notably the
sulcus cruciatus - and in a number of cases only this
part of the cortex - that accumulates PrP
Sc in its deeper
cortical layers (see Figure 2i). This stage is therefore
designated “cruciate sulcus stage”.P r P
Sc deposits in the
cerebellar cortex are not yet evenly distributed.
Basal ganglia stage: In the final stage, PrP
Sc deposits
can be seen also in the medial thalamic nuclei (medio-
dorsal, ventrolateral, ventral posterior and anterior
group), the corpora geniculata and the basal ganglia.
A positive staining for PrP
Sc in the latter determines a
classical case in our definition for the “basal ganglia
stage”. The white matter also displays remarkable
amounts of PrP
Sc, which are strongly linked to perivas-
cular distribution.
All stages are depicted in Figures 2, 3 and 4 and the
stage at which PrP
Sc reaches a respective neuroanatomi-
cal site is indicated in Figure 5 using a colour code. In
the sheep examined in this study we could not find any
influence of the different genotypes on the neuroanato-
mical distribution of PrP
Sc aggregates.
Comparison of PrP
Sc deposition patterns in classical
and atypical/Nor98 scrapie PrP
Sc deposits in atypical/
Nor98 scrapie cases were examined and evaluated in the
same way as with the classical field cases.
In contrast to the classical scrapie cases, differentiating
distribution/spread stages of PrP
Sc in the CNS was not fea-
sible with the atypical/Nor98 scrapie cases. In Figure 6, the
same brain sections that illustrate the different stages of
classical scrapie in Figure 2 are depicted for a case of aty-
pical/Nor98 scrapie. In all atypical/Nor98 scrapie sheep,
where brainstem material was available (n = 15) apart
from one (see below), PrP
Sc aggregates were detectable in
the rhombencephalon and mesencephalon. Regularly
affected neuroanatomical structures were the spinal tri-
geminal nucleus, reticular formation, pyramid, pontine
fibres, substantia nigra and cerebral peduncle. In the spinal
cord the corticospinal tract and substantia gelatinosa accu-
mulated PrP
Sc in most cases (Figure 1c). Certain grey mat-
ter structures such as the DMNV, hypoglossal nucleus,
dorsal tegmental nucleus, oculomotor nucleus, red nucleus
Figure 6 PrP
Sc distribution in the brain of atypical/Nor98 scrapie: Brain sections of an atypical/Nor98 scrapie case stained with the PET blot
(mAb P4) have a different PrP
Sc distribution than the ones of classical scrapie cases as shown in Figure 2 (bar = 5 mm). Brain section derived
from a sheep with the genotype ARQ/AHQ.
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Page 9 of 14and central grey of the mesencephalon, never displayed
any PrP
Sc in the examined atypical/Nor98 scrapie cases.
These listed neuroanatomical sites, however, accumulated
large amounts of PrP
Sc in the respective stage of PrP
Sc dis-
tribution in the CNS of classical scrapie sheep as explained
above (Figures 2, 3, 4 and 5). There were no PrP
Sc aggre-
gates detectable in the cerebellar nuclei of the examined
atypical/Nor98 scrapie cases, in contrast to the classical
scrapie cases as described above. The synaptic or reticular
PrP
Sc staining pattern in the cerebellar cortex of atypical/
Nor98 scrapie sheep was in most cases more intense in
the molecular than in the granular layer (Figure 1e). Intra-
and extracellular complex PrP
Sc aggregates in the cerebel-
lar cortex of classical scrapie sheep were predominantly
present in the granular layer and surrounding the Purkinje
cells; the molecular layer displayed mainly glia-associated
PrP
Sc deposits that took a stellate form (Figure 1d). The
cerebellar peduncles and white matter of the cerebellum
itself showed PrP
Sc aggregates for both scrapie types. In
the diencephalon of most atypical/Nor98 scrapie sheep,
the corpora geniculata, medial thalamic nuclei and reticu-
lar nucleus accumulated PrP
Sc aggregates. In all atypical/
Nor98 cases where the anterior striatum could be exam-
ined (n = 14), PrP
Sc deposits were also present in the cau-
date nucleus and putamen. The white matter of
diencephalon and telencephalon showed PrP
Sc deposits in
both types of sheep scrapie. In atypical/Nor98 scrapie,
these were mainly confined to the subcortical fibres and
certain white matter tracts, e.g. the corpus callosum or the
commissura rostralis (Figure 7d, arrow), while the distri-
bution in classical scrapie was more disseminated.
There was one case in which PrP
Sc deposits were
detectable with the PET blot only in the supratentorial
(cerebral) brain structures and to a very small degree in
the cerebellar cortex. The brainstem, including midbrain
and spinal cord, were completely spared in this case,
Figure 7 Differences in the neuroanatomical distribution of PrP
Sc deposit in atypical/Nor98 and classical sheep scrapie: In atypical/
Nor98 scrapie, white matter structures like the external capsule or rostral commissure contain substantially more PrP
Sc than the subcortical
nuclei or basal ganglia respectively (a and c), whereas this is the reverse in classical scrapie (b and d). The external capsule (a and b) and the
rostral commissure (c and d) are marked with arrows (mAb P4, bars = 1 mm). Tissue derived from sheep with the genotypes ARQ/AHQ (a), ARQ/
ARQ (b and d) and AHQ/AFRQ (c).
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stage of atypical/Nor98 scrapie [23].
In Figure 7 the contrasts in PrP
Sc intensity existing in
the grey and white matter between the two types of
scrapie are demonstrated in a case of atypical/Nor98
s c r a p i ea n dac l a s s i c a ls c r a p i ec a s eo ft h e“basal ganglia
stage": in classical scrapie it is the centromedial amygda-
loid nuclei (Figure 7b) as well as the septal nuclei and
basal ganglia (Figure 7d) that show substantially more
PrP
Sc than the external capsule (Figure 7b, arrow) and
the rostral commissure (Figure 7d, arrow). In atypical/
Nor98 scrapie, this principle turns out to be exactly the
opposite, with the external capsule (Figure 7a, arrow)
and the rostral commissure (Figure 7c, arrow) accumu-
lating rather intense PrP
Sc deposits in contrast to the
adjacent grey matter.
The lateral olfactory tract displayed PrP
Sc aggregates in
both scrapie types with the respective PrP
Sc deposition
patterns described above. Yet, the Islands of Calleja -
clusters of neuronal granular cells in the olfactory tuber-
cle - showed dense PrP
Sc deposits solely in classical
scrapie cases and were completely devoid of PrP
Sc in aty-
pical/Nor98 scrapie sheep. Regarding the hippocampus
formation in classical scrapie cases, there was usually a
more intense staining of the hippocampus and the fissura
hippocampi compared to the dentate gyrus. In contrast
to the atypical/Nor98 scrapie cases, there was no obvious
accentuation of any layers. Atypical/Nor98 scrapie sheep
showed a rather intense PrP
Sc staining of the granular
layer of the dentate gyrus, the fissura hippocampi and the
interconnective fibres between hippocampus and alveus
(similar to the subcortical white matter) in comparison to
the adjacent layers. The pyramid layer of the hippocam-
pus appeared to be completely devoid of PrP
Sc deposits.
The intensity of PrP
Sc s t a i n i n gi nas i n g l ec a s ew a s
usually in agreement with the intensity of PrP
Sc deposits
that could be found in the cerebral cortex of both scrapie
types. As mentioned above, the complex PrP
Sc aggregates
in classical scrapie were mainly confined to the deeper
cortical layers (laminae V and VI) while reticular/synaptic
PrP
Sc deposits in the cortices of atypical/Nor98 scrapie
sheep were distributed more evenly, although an accent-
uation of laminae I and IV could be noted in some cases.
Like in classical scrapie, differences regarding the dis-
tribution of PrP
Sc deposition could not be related to
genotypes.
Discussion
In this study 24 cases of classical and 25 cases of atypi-
cal/Nor98 scrapie cases were examined with the PET
blot method, focusing on the similarities and differences
in the distribution of PrP
Sc deposits that were detectable
with this method. Recently the PET blot has been
shown to provide a sensitive and specific detection of
PrP
Sc in both types of sheep scrapie in the same manner
as had been previously shown for human, bovine and
rodent neuronal and non-neuronal tissues [30,35,38-41].
The high sensitivity of this method allows PrP
Sc deposits
to be detected even in FFI patients where conventional
immunohistochemistry fails to detect them, and con-
trasts with Western blotting, which requires up to 1 g
of tissue equivalent [42]. The PET blot provides, apart
from its sensitivity and specificity, a good overview of
where to find PrP
Sc in a brain section (Figure 2), as no
counterstaining is necessary. The fine resolution of the
immunolabeling gives a good impression of the struc-
tures that accumulate PrP
Sc (Figure 1f), but the general
delineation of the single cell is better with immunohis-
tochemistry, which is why these two methods comple-
ment each other in a sensible way.
Neuroinvasion and spread of PrP
Sc in the ovine brain
In this study, we also give a more detailed account of
how the disease-associated PrP aggregates seem to
spread in the CNS tissue of sheep infected with classical
scrapie. The sequential detection of PrP
Sc aggregates in
the CNS of classical scrapie sheep implies that a cell-to-
cell spread takes place from the entry sites in the spinal
cord and obex to the cerebellum, diencephalon and
frontal cortex via the rostral brainstem. From these
entry sites we conclude that the vagus nerve for the
DMNV and sympathetic fibres for the spinal cord are
the structures that transport the infectious agent to the
CNS. This is very similar to the results obtained in ham-
sters after oral inoculation with the 263K scrapie strain
[43]. The cerebellum may also receive PrP
Sc via the cer-
ebellar tracts of the spinal cord. Noticeable perivascular
PrP
Sc deposition in the brains of scrapie-affected sheep
also raises the possibility that the infectious agent
reaches the brain via the haematogenous route [44]. The
distribution of brain metastases in humans reflects a
haematogenous entry into the brain as it is proportional
to the cerebral blood flow per area. From this one can
conclude that a general PrP
Sc uptake from the blood
would cause quite a different cerebral distribution pat-
tern of PrP
Sc deposits than we observed [45]. There are
three other possible explanations for the perivascular
accumulation of PrP
Sc aggregates in classical scrapie.
Cells of glial origin, e.g. microglia, might use the blood
vessels as a structural lead for their movement and carry
PrP
Sc molecules with them, possibly also distributing
them among the astrocytes forming the blood brain bar-
rier (BBB). This would be a vascular spread in the
broader sense. As a second possibility, microglia cells
that have incorporated PrP
Sc move to the blood vessels
in order to dispose of the aggregates and this leads to a
perivascular deposition of the aggregates. Another way
for PrP
Sc to reach blood vessels could be that they
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vorum perivascularis. Haematogenous neuroinvasion has
also been discussed with regard to the circumventricular
organs (CVOs) due to the fact that these are usually
affected in scrapie-infected sheep and that they are not
protected by the BBB [46]. The possibility that the
CVOs might be in contact with PrP
Sc from the blood
during the pathogenesis of the disease cannot be
excluded, but our results argue against a major involve-
ment of the CVOs in neuroinvasion. In a very early case
the DMNV was affected, but the area postrema and
further CVOs were devoid of PrP
Sc (Figure 2d). This
agrees again with the results obtained for the oral infec-
tion of hamsters with scrapie [30].
In contrast to the classical scrapie cases, a sequential
development of PrP
Sc distribution cannot be seen upon
analysis of the present atypical/Nor98 scrapie cases.
PrP
Sc distribution in one sheep of presumably early dis-
ease phase suggests that the aggregation of PrP
Sc has its
origin in the di- or telencephalon. A spontaneous gen-
esis of misfolded PrP could arise in the cerebral cortex.
On the other hand, an ascending spread of the infec-
tious agent that bypasses the brainstem and enters the
CNS via sensible nerve fibres should be taken into con-
sideration, e.g. proprioceptive fibres [47] or the spi-
nothalamic tract. This would lead to further spreading
of PrP
Sc from the thalamic nuclei to the cerebellar and
cerebral cortex and from these to the brainstem and
spinal cord, e.g. via the corticospinal tract.
Where does the spread of Nor98- PrP
Sc start in the brain?
It has been speculated by Nentwig et al. [48] that the
PrP
Sc deposits and histopathologic lesions in atypical/
Nor98 scrapie possibly evolve from the cerebrum to the
cerebellum and the brainstem, but according to their
examination of six sheep brains, this concept would not
explain the PrP
Sc distribution in one sheep where they
found PrP
Sc mainly in the cerebellum. However, immu-
nohistochemistry - as used by these authors - is some-
times not able to detect the fine reticular deposits, e.g.
seen in the cortex of Creutzfeldt-Jakob disease type 1,
especially in the rare VV1 subtype [49]. The sensitive
PET blot method, in contrast, is able to visualize these
reticular deposits [38]. PrP
Sc deposits in one case
described by Nentwig et al. could have therefore simply
been missed in the cortex by immunohistochemistry. If
this proved to be correct, according to the argumenta-
tion of Nentwig et al., PrP
Sc deposition and histopatho-
logic lesions could indeed evolve from the cerebrum
into the cerebellum and the brainstem. The 15 whole
brains of atypical/Nor98 scrapie sheep examined by
Moore et al. [21] should accordingly represent more or
less the final stage of disease, as PrP
Sc can be generally
found in all parts of the brain, including the brainstem.
In other reports on the occurrence of atypical/Nor98
scrapie, cases have been described in which no PrP
Sc
was detectable by immunohistochemistry in the obex
region at all, but in the cerebellum and cerebrum
[50-54]. If the misfolding of PrP
c in atypical/Nor98 scra-
pie does really start in the cerebrum it is obvious why
early stages are not present in the worldwide pool of
preserved atypical/Nor98 brains, as only the sampling of
brainstem and cerebellum is compulsory in small rumi-
nants according to EU regulations. Thus the question of
whether PrP
Sc accumulation might start sporadically in
the cerebrum - and if so, at one or more sites at the
same time? - cannot be resolved by this or any other
current study using field cases of atypical/Nor98 scrapie.
This situation is comparable to the one with CJD type
1, where a spontaneous misfolding of PrP
c in the cere-
bral cortex and a caudal spread from there is assumed,
but not proven [55]. The incidence of atypical/Nor98 in
sheep is higher than that of CJD in humans [17]. A case
control study of atypical/Nor98 scrapie has shown that
animal movement does not seem to be a factor for the
transmission of atypical/Nor98 scrapie between flocks;
thus if sheep were to acquire this prion disease from
their environment, its contagiousness would indeed be
very low [56]. It has been speculated that this might be
due to the relatively low protease stability, which could
also explain the lack of intracellular PrP
Sc deposits [33].
There are certainly small differences between the
PrP
Sc distribution detected by Moore et al. [21] in their
described atypical/Nor98 scrapie cases and the ones
revealed here by the PET blot method. For instance, in
the present atypical/Nor98 scrapie material, PrP
Sc was
never detectable in the cerebellar nuclei. Also, the
affected parts of the hippocampus appear to be different.
This might be due to differences in the treatment of tis-
sue, the methods and/or differences in the antibodies
used (mAb2G11 versus mAbP4). As previously reported,
perineuronal staining has also been detected for the sub-
stantia nigra in some atypical/Nor98 scrapie sheep using
immunohistochemistry [11], whereas in our study only
plaque-like PrP
Sc deposits could be seen in this neuroa-
natomical structure. Similarly, neuronal deposits could
be found in many affected sites of classical scrapie, but
in contrast to previous publications [22], neither PET
blot nor immunohistochemistry revealed PrP
Sc in the
Purkinje cells of the cerebellum. It is known that espe-
cially intraneuronal immunoreactivity needs to be inter-
preted with caution [10]. However, the congruence
between previous reports on PrP
Sc deposition patterns
and the present results is obvious.
Conclusion
In summary, this study gives a basic description of PrP
Sc
deposition patterns in classical as compared to atypical/
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blot method. We were able show a sequential appear-
ance of PrP
Sc aggregates in the CNS of sheep with clas-
sical scrapie, but not in atypical/Nor98 scrapie. The four
emerging stages of spread in classical scrapie were
defined by the accumulation of PrP
Sc in certain neuroa-
natomical structures. These structures accumulated
PrP
Sc aggregates in all animals belonging to this stage
and the following stage/stages. Further conclusions
drawn from this study regarding atypical/Nor98 scrapie
might help in future to elucidate its origin and poten-
tially related prion disease types like Creutzfeldt-Jakob
disease type 1.
Acknowledgements
We would like to thank Tatjana Pfander, Nadine Rupprecht and Kerstin
Brekerbohm for their skilful technical assistance. The work was supported by
the VolkswagenStiftung (grants ZN 1294 and ZN 2168 to W.J.S.S).
Author details
1Prion and Dementia Research Unit, Department of Neuropathology,
University Medical Center, Georg-August University, Robert-Koch Str. 40,
37075 Goettingen, Germany.
2Norwegian Veterinary Institute, P.O. Box 750
Sentrum, 0106 Oslo, Norway.
3Institute of Veterinary Medicine, Faculty for
Agricultural Sciences, Georg-August University, Burckhardweg 2, 37075
Goettingen, Germany.
Authors’ contributions
WMW carried out the PET blot studies, participated in
immunohistochemistry, Western blot, tissue acquisition and the design of
the study and drafted the manuscript. SLB participated in
immunohistochemistry, Western blot, tissue acquisition and design of the
study and co-edited the manuscript. AW, WEW, BeB and BjB participated in
tissue acquisition and diagnosing the cases. WJSS conceived the study,
participated in its design and coordination and co-edited the manuscript. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 20 September 2010 Accepted: 15 February 2011
Published: 15 February 2011
References
1. McGowan JP: Scrapie in sheep. Scottish J Agric 1922, 5:365-375.
2. Prusiner SB: Novel proteinaceous infectious particles cause scrapie.
Science 1982, 216:136-144.
3. Oesch B, Westaway D, Walchli M, McKinley MP, Kent SB, Aebersold R,
Barry RA, Tempst P, Teplow DB, Hood LE, Prusiner SB, Weissmann C: A
cellular gene encodes scrapie PrP 27-30 protein. Cell 1985, 40:735-746.
4. Wang F, Wang X, Yuan CG, Ma J: Generating a prion with bacterially
expressed recombinant prion protein. Science 2010, 327:1132-1135.
5. Bendheim PE, Brown HR, Rudelli RD, Scala LJ, Goller NL, Wen GY,
Kascsak RJ, Cashman NR, Bolton DC: Nearly ubiquitous tissue distribution
of the scrapie agent precursor protein. Neurology 1992, 42:149-156.
6. Bruce ME, Boyle A, Cousens S, McConnell I, Foster J, Goldmann W, Fraser H:
Strain characterization of natural sheep scrapie and comparison with
BSE. J Gen Virol 2002, 83:695-704.
7. Hope J, Wood SC, Birkett CR, Chong A, Bruce ME, Cairns D, Goldmann W,
Hunter N, Bostock CJ: Molecular analysis of ovine prion protein identifies
similarities between BSE and an experimental isolate of natural scrapie,
CH1641. J Gen Virol 1999, 80:1-4.
8. Stack MJ, Chaplin MJ, Clark J: Differentiation of prion protein glycoforms
from naturally occurring sheep scrapie, sheep-passaged scrapie strains
(CH1641 and SSBP1), bovine spongiform encephalopathy (BSE) cases
and Romney and Cheviot breed sheep experimentally inoculated with
BSE using two monoclonal antibodies. Acta Neuropathol 2002,
104:279-286.
9. Benestad SL, Sarradin P, Thu B, Schönheit J, Tranulis MA, Bratberg B: Cases
of scrapie with unusual features in Norway and designation of a new
type, Nor98. Vet Rec 2003, 153:202-208.
10. EFSA: Opinion of the Scientific Panel on Biological Hazards on
classification of atypical Transmissible Spongiform Encephalopathy (TSE)
cases in Small Ruminants. The EFSA Journal 2005, 276:1-30.
11. Benestad SL, Arsac JN, Goldmann W, Nöremark M: Atypical/Nor98 scrapie:
properties of the agent, genetics, and epidemiology. Vet Res 2008, 39:19.
12. Wemheuer WM, Benestad SL, Wrede A, Schulze-Sturm U, Wemheuer WE,
Hahmann U, Gawinecka J, Schütz E, Zerr I, Brenig B, Bratberg B,
Andreoletti O, Schulz-Schaeffer WJ: Similarities between forms of sheep
scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion
types. Am J Pathol 2009, 175:2566-2573.
13. Simon S, Nugier J, Morel N, Boutal H, Créminon C, Benestad SL,
Andréoletti O, Lantier F, Bilheude JM, Feyssaguet M, Biacabe AG, Baron T,
Grassi J: Rapid typing of transmissible spongiform encephalopathy
strains with differential ELISA. Emerg Infect Dis 2008, 14:608-616.
14. Belt PB, Muileman IH, Schreuder BE, Bos-de Ruijter J, Gielkens AL, Smits MA:
Identification of five allelic variants of the sheep PrP gene and their
association with natural scrapie. J Gen Virol 1995, 76:509-517.
15. Hunter N: PrP genetics in sheep and the applications for scrapie and
BSE. Trends Microbiol 1997, 5:331-334.
16. Lühken G, Buschmann A, Groschup MH, Erhardt G: Prion protein allele A136
H154Q171 is associated with high susceptibility to scrapie in purebred
and crossbred German Merinoland sheep. Arch Virol 2004, 149:1571-1580.
17. Lühken G, Buschmann A, Brandt H, Eiden M, Groschup MH, Erhardt G:
Epidemiological and genetical differences between classical and atypical
scrapie cases. Vet Res 2007, 38:65-80.
18. Moum T, Olsaker I, Hopp P, Moldal T, Valheim M, Moum T, Benestad SL:
Polymorphisms at codons 141 and 154 in the ovine prion protein gene
are associated with scrapie Nor98 cases. J Gen Virol 2005, 86:231-235.
19. González L, Martin S, Begara-McGorum I, Hunter N, Houston F, Simmons M,
Jeffrey M: Effects of agent strain and host genotype on PrP
accumulation in the brain of sheep naturally and experimentally
affected with scrapie. J Comp Pathol 2002, 126:17-29.
20. Miller JM, Jenny AL, Taylor WD, Marsh RF, Rubenstein R, Race RE:
Immunohistochemical detection of prion protein in sheep with scrapie. J
Vet Diagn Invest 1993, 5:309-316.
21. Moore SJ, Simmons M, Chaplin M, Spiropoulos J: Neuroanatomical
distribution of abnormal prion protein in naturally occurring atypical
scrapie cases in Great Britain. Acta Neuropathol 2008, 116:547-559.
22. van Keulen LJ, Schreuder BE, Meloen RH, Poelen-van den Berg M, Mooij-
Harkes G, Vromans ME, Langeveld JP: Immunohistochemical detection
and localization of prion protein in brain tissue of sheep with natural
scrapie. Vet Pathol 1995, 32:299-308.
23. Wemheuer WM, Benestad SL, Wrede A, Wemheuer WE, Brenig B,
Bratberg B, Schulz-Schaeffer WJ: Detection of classical and atypical/Nor98
scrapie by the paraffin-embedded tissue blot method. Vet Rec 2009,
164:677-681.
24. Andréoletti O, Simon S, Lacroux C, Morel N, Tabouret G, Chabert A,
Lugan S, Corbière F, Ferre P, Foucras G, Laude H, Eychenne F, Grassi J,
Schelcher F: PrPSc accumulation in myocytes from sheep incubating
natural scrapie. Nat Med 2004, 10:591-593.
25. Lacroux C, Corbière F, Tabouret G, Lugan S, Costes P, Mathey J, Delmas JM,
Weisbecker JL, Foucras G, Cassard H, Elsen JM, Schelcher F, Andreoletti O:
Dynamics and genetics of PrPSc placental accumulation in sheep. J Gen
Virol 2007, 88:1056-1061.
26. Ligios C, Sigurdson CJ, Santucciu C, Carcassola G, Manco G, Basagni M,
Maestrale C, Cancedda MG, Madau L, Aguzzi A: PrPSc in mammary glands
of sheep affected by scrapie and mastitis. Nat Med 2005, 11:1137-1138.
27. Thomzig A, Schulz-Schaeffer W, Wrede A, Wemheuer W, Brenig B, Kratzel C,
Lemmer K, Beekes M: Accumulation of pathological prion protein PrPSc
in the skin of animals with experimental and natural scrapie. PLoS
Pathog 2007, 3:e66.
28. Ersdal C, Ulvund MJ, Espenes A, Benestad SL, Sarradin P, Landsverk T:
Mapping PrPSc propagation in experimental and natural scrapie in
sheep with different PrP genotypes. Vet Pathol 2005, 42:258-274.
29. van Keulen LJ, Schreuder BE, Vromans ME, Langeveld JP, Smits MA:
Pathogenesis of natural scrapie in sheep. Arch Virol Suppl 2000, 57-71.
Wemheuer et al. Veterinary Research 2011, 42:32
http://www.veterinaryresearch.org/content/42/1/32
Page 13 of 1430. McBride PA, Schulz-Schaeffer WJ, Donaldson M, Bruce M, Diringer H,
Kretzschmar HA, Beekes M: Early spread of scrapie from the
gastrointestinal tract to the central nervous system involves autonomic
fibers of the splanchnic and vagus nerves. J Virol 2001, 75:9320-9327.
31. van Keulen LJ, Vromans ME, Dolstra CH, Bossers A, Van Zijderveld FG:
Pathogenesis of bovine spongiform encephalopathy in sheep. Arch Virol
2008, 153:445-453.
32. Ryder SJ, Dexter GE, Heasman L, Warner R, Moore SJ: Accumulation and
dissemination of prion protein in experimental sheep scrapie in the
natural host. BMC Vet Res 2009, 5:9.
33. Simmons MM, Konold T, Simmons HA, Spencer YI, Lockey R, Spiropoulos J,
Everitt S, Clifford D: Experimental transmission of atypical scrapie to
sheep. BMC Vet Res 2007, 3:20.
34. Schütz E, Scharfenstein M, Brenig B: Genotyping of ovine prion protein
gene (PRNP) variants by PCR with melting curve analysis. Clin Chem
2006, 52:1426-1429.
35. Schulz-Schaeffer WJ, Fatzer R, Vandevelde M, Kretzschmar HA: Detection of
PrP(Sc) in subclinical BSE with the paraffin-embedded tissue (PET) blot.
Arch Virol Suppl 2000, 173-180.
36. González L, Martin S, Jeffrey M: Distinct profiles of PrP(d)
immunoreactivity in the brain of scrapie- and BSE-infected sheep:
implications for differential cell targeting and PrP processing. J Gen Virol
2003, 84:1339-1350.
37. Kitamoto T, Tateishi J: Human prion diseases with variant prion protein.
Philos Trans R Soc Lond B Biol Sci 1994, 343:391-398.
38. Schulz-Schaeffer WJ, Tschöke S, Kranefuss N, Dröse W, Hause-Reitner D,
Giese A, Groschup MH, Kretzschmar HA: The paraffin-embedded tissue
blot detects PrP(Sc) early in the incubation time in prion diseases. Am J
Pathol 2000, 156:51-56.
39. Lezmi S, Bencsik A, Baron T: PET-blot Analysis Contributes to BSE Strain
Recognition in C57Bl/6 Mice. J Histochem Cytochem 2006, 54:1087-1094.
40. Peden AH, Ritchie DL, Head MW, Ironside JW: Detection and localization
of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and
sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 2006,
168:927-935.
41. Thomzig A, Kratzel C, Lenz G, Krüger D, Beekes M: Widespread PrPSc
accumulation in muscles of hamsters orally infected with scrapie. EMBO
Rep 2003, 4:530-533.
42. Reder AT, Mednick AS, Brown P, Spire JP, Van Cauter E, Wollmann RL,
Cervenakova L, Goldfarb LG, Garay A, Ovsiew F, Gajdusek DC, Roos RP:
Clinical and genetic studies of fatal familial insomnia. Neurology 1995,
45:1068-1075.
43. Schulz-Schaeffer W, McBride PA, Beekes M, Kretzschmar HA: Spread of
PrPSc in orally infected animals during incubation time of prion disease.
XIV International Conference of Neuropathology 2000, 663.
44. Jeffrey M, Goodsir CM, Holliman A, Higgins RJ, Bruce ME, McBride PA,
Fraser JR: Determination of the frequency and distribution of vascular
and parenchymal amyloid with polyclonal and N-terminal-specific PrP
antibodies in scrapie-affected sheep and mice. Vet Rec 1998, 142:534-537.
45. Delattre JY, Krol G, Thaler HT, Posner JB: Distribution of brain metastases.
Arch Neurol 1988, 45:741-744.
46. Sisó S, Jeffrey M, González L: Neuroinvasion in sheep transmissible
spongiform encephalopathies: the role of the haematogenous route.
Neuropathol Appl Neurobiol 2009, 35:232-246.
47. Rüb U, Schultz C, Del TK, Gierga K, Reifenberger G, de Vos RA, Seifried C,
Braak H, Auburger G: Anatomically based guidelines for systematic
investigation of the central somatosensory system and their application
to a spinocerebellar ataxia type 2 (SCA2) patient. Neuropathol Appl
Neurobiol 2003, 29:418-433.
48. Nentwig A, Oevermann A, Heim D, Botteron C, Zellweger K, Drogemuller C,
Zurbriggen A, Seuberlich T: Diversity in Neuroanatomical Distribution of
Abnormal Prion Protein in Atypical Scrapie. PLoS Pathog 2007, 3:e82.
49. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I,
Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J,
Vital C, Ghetti B, Gambetti P, Kretzschmar H: Classification of sporadic
Creutzfeldt-Jakob disease based on molecular and phenotypic analysis
of 300 subjects. Ann Neurol 1999, 46:224-233.
50. Buschmann A, Biacabe AG, Ziegler U, Bencsik A, Madec JY, Erhardt G,
Lühken G, Baron T, Groschup MH: Atypical scrapie cases in Germany and
France are identified by discrepant reaction patterns in BSE rapid tests. J
Virol Methods 2004, 117:27-36.
51. Buschmann A, Lühken G, Schultz J, Erhardt G, Groschup MH: Neuronal
accumulation of abnormal prion protein in sheep carrying a scrapie-
resistant genotype (PrPARR/ARR). J Gen Virol 2004, 85:2727-2733.
52. Gavier-Widen D, Nöremark M, Benestad S, Simmons M, Renstrom L,
Bratberg B, Elvander M, af Segerstad CH: Recognition of the Nor98 variant
of scrapie in the Swedish sheep population. J Vet Diagn Invest 2004,
16:562-567.
53. Onnasch H, Gunn HM, Bradshaw BJ, Benestad SL, Bassett HF: Two Irish
cases of scrapie resembling Nor98. Vet Rec 2004, 155:636-637.
54. Orge L, Galo A, Machado C, Lima C, Ochoa C, Silva J, Ramos M, Simas JP:
Identification of putative atypical scrapie in sheep in Portugal. J Gen Virol
2004, 85:3487-3491.
55. Heye N, Cervos-Navarro J: Focal involvement and lateralization in
Creutzfeldt-Jakob disease: correlation of clinical,
electroencephalographic and neuropathological findings. Eur Neurol
1992, 32:289-292.
56. Hopp P, Omer MK, Heier BT: A case-control study of scrapie Nor98 in
Norwegian sheep flocks. J Gen Virol 2006, 87:3729-3736.
doi:10.1186/1297-9716-42-32
Cite this article as: Wemheuer et al.: PrP
Sc spreading patterns in the
brain of sheep linked to different prion types. Veterinary Research 2011
42:32.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Wemheuer et al. Veterinary Research 2011, 42:32
http://www.veterinaryresearch.org/content/42/1/32
Page 14 of 14